St. Jude Medical, St. Paul, Minn., has completed its $185 million acquisition of Epicor Medical, Sunnyvale, Calif., a developer of ultrasound devices specially designed for surgically treating irregular heartbeats. St. Jude bought an initial stake in Epicor in May 2003 for $15 million and conditionally agreed to a full acquisition. In the 13 months since, Epicor met or exceeded all regulatory and clinical milestones set as conditions for the full acquisition, officials said. St. Jude officials said the acquisition strengthens the company's position in the treatment of cardiac rhythm disorders, including atrial fibrillation, a progressive condition that affects 6 million people worldwide. -- by Cinda Becker
St. Jude buys cardiac company for $185 million
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.